We are live on ! Find out more
EFM

EQT Fund Management Portfolio holdings

AUM $863M
1-Year Est. Return 26.03%
This Fund
S&P 500
This Quarter Est. Return
-7.93%
1 Year Est. Return
-26.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
-$91.3M
Cap. Flow
+$72.8M
Cap. Flow %
7.13%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AGMB
AgomAb Therapeutics NV
AGMB
+$72.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAY
1
Waystar Holding Corp
WAY
$4.81B
$600M 58.77%
24,879,437
– –
OCS icon
2
Oculis Holding
OCS
$712M
$157M 15.37%
5,900,294
– –
EVMN
3
Evommune Inc
EVMN
$511M
$113M 11.1%
4,929,633
– –
PHVS icon
4
Pharvaris
PHVS
$2.38B
$96.7M 9.48%
3,424,609
– –
AGMB
5
AgomAb Therapeutics NV
AGMB
$687M
$53.9M 5.28%
+5,141,992
New +$72.8M

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return

EQT Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, EQT Fund Management held 5 positions worth $1.02B, down 8.2% from $1.11B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

EQT Fund Management deployed $72.8M of net new capital in Q1 2026, opening 1 new position. Its largest new stake was AgomAb Therapeutics NV: 5,141,992 shares worth $53.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • EQT Fund Management's largest Q1 2026 buy was AgomAb Therapeutics NV: 5,141,992 shares worth $53.9M.
  • EQT Fund Management's ten largest holdings make up 100% of its $1.02B portfolio in Q1 2026.
  • EQT Fund Management opened 1 new position and closed 0 in Q1 2026.
  • EQT Fund Management's portfolio value fell 8.2% quarter-over-quarter to $1.02B.

Based on EQT Fund Management's 13F filing for Q1 2026, filed 14 May 2026.